ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,572.07
-0.76%
US Tech 100
18,879.20
-0.16%
다우존스 지수
41,433.48
-1.14%
Bitcoin
83,187.77
6.01%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Biodesix Inc (BDSX) 시세

Biodesix Inc

Biodesix Inc (BDSX)

NASDAQ
0.8161
0.0098
(1.22%)
종가: 12 3월 5:00AM
15분 지연
0.8161
0.00
( 0.00% )
시간외 거래: 5:58AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
0.8161
매수가
0.7804
매도가
0.83
거래량
220,878
0.766 일간 변동폭 0.8234
0.635 52주 범위 2.04
market_cap
118.716M
전일 종가
0.8063
개장가
0.81
최근 거래 시간
2
@
0.85
마지막 거래 시간
05:09:37
재정 규모
US$ 175,432
VWAP
0.794248
평균 볼륨(3m)
440,931
발행 주식
145,467,295
배당수익률
-
주가수익률
-2.29
주당순이익(EPS)
-0.36
매출
49.09M
순이익
-52.15M

Biodesix Inc 정보

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. 더 보기

섹터
Medical Laboratories
산업
Medical Laboratories
웹사이트
www.biodesix.com
본부
Wilmington, Delaware, USA
설립됨
-
Biodesix Inc is listed in the Medical Laboratories sector of the 나스닥 with ticker BDSX. The last closing price for Biodesix was US$0.81. Over the last year, Biodesix shares have traded in a share price range of US$ 0.635 to US$ 2.04.

Biodesix currently has 145,467,295 shares in issue. The market capitalisation of Biodesix is US$117.29 million. Biodesix has a price to earnings ratio (PE ratio) of -2.29.

BDSX 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
04 3월 2025
BDSX (1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 2월 2025
BDSX (1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 2월 2025
BDSX (1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 2월 2025
BDSX (1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 2월 2025
BDSX (1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 2월 2025
BDSX (1.22%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 2월 2025
BDSX (1.22%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.178427.97553708640.63770.95660.63514385420.75452104CS
4-0.1212-12.93075856180.93731.020.6355530190.79335175CS
12-0.5539-40.43065693431.371.610.6354409311.01554397CS
26-0.9539-53.89265536721.771.860.6354222501.21710961CS
52-0.6639-44.85810810811.482.040.6352799541.29778393CS
156-1.4439-63.8893805312.2630.6352131371.54643096CS
260-12.7739-93.994849153813.5931.990.6351896453.92360129CS

BDSX - Frequently Asked Questions (FAQ)

What is the current Biodesix share price?
The current share price of Biodesix is US$ 0.8161
How many Biodesix shares are in issue?
Biodesix has 145,467,295 shares in issue
What is the market cap of Biodesix?
The market capitalisation of Biodesix is USD 117.29M
What is the 1 year trading range for Biodesix share price?
Biodesix has traded in the range of US$ 0.635 to US$ 2.04 during the past year
What is the PE ratio of Biodesix?
The price to earnings ratio of Biodesix is -2.29
What is the cash to sales ratio of Biodesix?
The cash to sales ratio of Biodesix is 2.43
What is the reporting currency for Biodesix?
Biodesix reports financial results in USD
What is the latest annual turnover for Biodesix?
The latest annual turnover of Biodesix is USD 49.09M
What is the latest annual profit for Biodesix?
The latest annual profit of Biodesix is USD -52.15M
What is the registered address of Biodesix?
The registered address for Biodesix is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Biodesix website address?
The website address for Biodesix is www.biodesix.com
Which industry sector does Biodesix operate in?
Biodesix operates in the MEDICAL LABORATORIES sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
HCTIHealthcare Triangle Inc
US$ 0.506
(55.69%)
13.2M
SSPEW Scripps Company
US$ 1.90
(32.87%)
825.15k
ONEGOneConstruction Group Limited
US$ 2.71
(20.44%)
1.29k
SFIXStitch Fix Inc
US$ 5.05
(19.39%)
2.1M
PALIPalisade Bio Inc
US$ 1.10
(17.02%)
82.97k
SHLTSHL Telemedicine Ltd
US$ 1.65
(-36.54%)
6.16k
HEPAHepion Pharmaceuticals Inc
US$ 0.0538
(-35.95%)
21.21M
ZYXIZynex Inc
US$ 5.54
(-20.86%)
21.13k
TNONTenon Medical Inc
US$ 1.20
(-20.53%)
1.22M
SYRSSyros Pharmaceuticals Inc
US$ 0.111
(-18.38%)
4.1M
HEPAHepion Pharmaceuticals Inc
US$ 0.0538
(-35.95%)
21.21M
HCTIHealthcare Triangle Inc
US$ 0.506
(55.69%)
13.2M
ICONIcon Energy Corporation
US$ 0.106
(-7.83%)
5.04M
NVDANVIDIA Corporation
US$ 108.55
(-0.19%)
4.53M
TSLATesla Inc
US$ 231.06
(0.21%)
4.12M

BDSX Discussion

게시물 보기
georgie18 georgie18 6 일 전
BDSX...96...🥳

georgie18

Member Level
Re: georgie18 post# 18

Wednesday, March 05, 2025 12:01:26 PM

Post#
20
of 20
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
georgie18 georgie18 6 일 전
BDSX...92s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670653

Wednesday, March 05, 2025 11:03:48 AM

Post#
676211
of 676223
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
TrendTrade2016 TrendTrade2016 6 일 전
BDSX....SLOW GRIND TO A DOLLA
👍️0
georgie18 georgie18 6 일 전
BDSX....82...Off the .65 Bottom...🥳...Added this bottom...https://schrts.co/HFpbquXc

georgie18

Member Level
Re: None

Tuesday, January 07, 2025 7:47:47 AM

Post#
670653
of 676211
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
TrendTrade2016 TrendTrade2016 1 주 전
BDSX BOTTOM BUSTER
👍️0
georgie18 georgie18 2 월 전
BDSX...$1.55...🥳...https://www.globenewswire.com/news-release/2025/01/07/3005157/0/en/Biodesix-Announces-Publication-of-a-New-Nodify-CDT-Clinical-Validation-Study.html
👍️0
PonkenPlonken PonkenPlonken 3 월 전
Mr Schuler is buying shares again
👍️0
tw0122 tw0122 4 월 전
Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
👍️0
tw0122 tw0122 4 월 전
Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
👍️0
AJ Freely AJ Freely 2 년 전
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
👍️0
1hot toddy 1hot toddy 2 년 전
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
👍️0
Leg58 Leg58 2 년 전
Lots if potential but will public offering dilute price?
👍️0
Leg58 Leg58 2 년 전
Lots if potential but will public offering dilute price?
👍️0
subslover subslover 2 년 전
Earnings look good.
👍️0
subslover subslover 2 년 전
Earnings look good.
👍️0
MiamiGent MiamiGent 2 년 전
BDSX Has news this morning!

The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGS™ testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
👍️0
carusso carusso 2 년 전
Not so much...
👍️0
crudeoil24 crudeoil24 3 년 전
LET'S GO BDSX !!!!!
👍️0
crudeoil24 crudeoil24 3 년 전
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
👍️0
crudeoil24 crudeoil24 3 년 전
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
👍️0
Leg58 Leg58 3 년 전
US based company is quietly trending up. IMHO.
GLTA
👍️0

최근 히스토리

NASDAQ
BDSX
Biodesix
AQSE
LIO.GB
Liontrust Asset Management
AMEX
RWK
Invesco S&P MidCap 400 R...
NASDAQI
ADREM
BLDRS Emerging Markets 5...
BIT
P05065
Bnp Paribas Issuance
LSE
75FE
Sg Issuer 23
TG
0LI2
WisdomTree Foreign Excha...
BIT
Q00214
Leonteq Securities
TG
DWNK
Deutsche Wohnen
TG
A30VMU
RWE
DOWI
DWCTIR
DJ US Tires Total Stock ...
BIT
P1P3F7
BNP Paribas Issuance
BIT
P1KUK7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지